D-Dimer Market Size

D-Dimer Market Analysis

The D-Dimer Market is expected to register a CAGR of 5.1% during the forecast period.

The emergence of COVID-19 led to a slight decline in the D-Dimer market during the initial phases of the pandemic, as there was a lack of availability of tests due to stringent lockdowns and production and manufacturing halts. But during the late stages, the pandemic had a significant impact on the market study as raising D-Dimer values can help identify people who can be at higher risk of COVID-19 complications, including disseminated intravascular coagulation and multi-organ failure. For instance, according to an article published in Dove Press in March 2022, coagulation disorders and acute respiratory failure were the prevailing causes of death from COVID-19. Together with other parameters that constitute the risk profile for severe COVID-19 evolution, the D-Dimers dosing at admission proved to be extremely useful in the management of COVID-19. Furthermore, during the post-pandemic phase, the market has seen a surge due to the rising adoption of D-Dimer, as this act as a biomarker for mortality in COVID-19 patients. For instance, according to another article published in Plos One, the D-Dimer value on admission was an accurate biomarker for predicting mortality in patients with COVID-19. This has led to the rising adoption of D-Dimer testing for the management of COVID-19 disease. Hence, the COVID-19 pandemic had a favorable impact on the market initially. Currently, as the pandemic has subsided, the market has lost some traction. However, it is expected to have stable growth during the forecast period.

A paradigm shift toward the demand for next-generation point-of-care D-Dimer testing has driven the market owing to the implementation of POC solutions significantly reducing waiting time, minimizing the length of patient stay, enabling faster diagnosis, and resulting in improved patient experience. The resounding benefits gained from these solutions in POC settings are considered to boost the growth of the market for D-Dimer testing. A rise in the incidence rate of Venous Thromboembolism (VTE), along with various pulmonary and cardiovascular diseases that cause life-threatening issues due to blood clot formation, is increasing the demand for D-Dimer testing.

According to a study published by the British Heart Foundation in August 2022, there were approximately 7.6 million people with heart and circulatory disease in the United Kingdom. Therefore, due to the high burden of cardiovascular diseases in developed countries such as the United Kingdom, there is an increasing demand for diagnostics assay, which can decrease the mortality rates associated with heart failure, thereby increasing the demand for D-Dimer assay during the study period.

According to an article published in the BMJ in February 2022, the diagnostic strategy using a combination of clinical pretest probability and D-Dimer identified patients at low risk for deep vein thrombosis during follow-up while substantially reducing the need for ultrasound imaging. Therefore, the importance of the D-Dimer test in identifying DVT helps in increased adoption, driving the market growth.

Therefore, owing to the aforementioned factors, the studied market is expected to grow significantly during the study period. However, the stringent regulation and limitations associated with the tests are expected to hinder the market growth during the study period.